Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome MDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004997
What this trial is testing

Leucovorin for the Treatment of 5 q Minus Syndrome

Who this might be right for
5q Minus SyndromeMyelodysplastic Syndrome
National Institutes of Health Clinical Center (CC) 14
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Not applicableStudy completedNCT00039923
What this trial is testing

Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Hemoglobinuria
National Heart, Lung, and Blood Institute (NHLBI) 7
Testing effectiveness (Phase 2)Study completedNCT02363491
What this trial is testing

A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Opsona Therapeutics Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT01599325
What this trial is testing

Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome (MDS)
Celgene 72
Early research (Phase 1)Study completedNCT01399840
What this trial is testing

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia+1 more
Pfizer 33
Testing effectiveness (Phase 2)UnknownNCT06247917
What this trial is testing

Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS

Who this might be right for
Myelodysplastic Syndrome With Excess Blasts-1Myelodysplastic Syndrome With Excess Blasts-2Myelodysplastic Syndromes
Ruijin Hospital 59
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00778375
What this trial is testing

Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 122
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Early research (Phase 1)Study completedNCT04718844
What this trial is testing

A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome

Who this might be right for
Non-transfusion-dependent ThalassemiaLow Risk Myelodysplastic SyndromeVery-Low Risk Myelodysplastic Syndrome
Silence Therapeutics plc 44
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Not applicableUnknownNCT04889729
What this trial is testing

GENOMED4ALL: Improving MDS Classification and Prognosis by AI

Who this might be right for
Myelodysplastic Syndromes
Istituto Clinico Humanitas 13,284
Early research (Phase 1)Study completedNCT00624936
What this trial is testing

Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center 23
Large-scale testing (Phase 3)Looking for participantsNCT06934967
What this trial is testing

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Ended earlyNCT02706899
What this trial is testing

Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS

Who this might be right for
Myelodysplastic Syndrome
Seagen Inc. 19
Early research (Phase 1)Ended earlyNCT01957644
What this trial is testing

Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Boehringer Ingelheim 16
Early research (Phase 1)Ended earlyNCT03588936
What this trial is testing

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

Who this might be right for
Acute LeukemiaChronic LeukemiaLymphoma+1 more
Medical College of Wisconsin 2
Testing effectiveness (Phase 2)Study completedNCT04330534
What this trial is testing

First-in-Human Study of BCX9930 in Healthy Volunteers and Patients With PNH

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
BioCryst Pharmaceuticals 168
Testing effectiveness (Phase 2)Looking for participantsNCT06303193
What this trial is testing

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Who this might be right for
Myelodysplastic Syndromes
National Cancer Institute (NCI) 160
Next Page